IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 20-F/A SEC Filings
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
[Amend]
TRINITY BIOTECH PLC, 20-F/A, 2000-04-05
BIOCHEM PHARMA INC, 20-F/A, 1998-06-03
BIOCHEM PHARMA INC, 20-F/A, 1998-05-27
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
